50 Participants Needed

Bone Grafts for Tooth Extractions

(FDBA or CEBX Trial)

EA
NA
Overseen ByNasser Assery, BDS, MS
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial requires that you do not take certain medications like immunosuppressants, steroids, bisphosphonates, or others related to jaw bone issues. If you are on these medications, you may need to stop them to participate.

What data supports the effectiveness of the treatment CEBX for bone grafts in tooth extractions?

Research shows that components like demineralized freeze-dried bone allograft (DFDBA) and bovine-derived bone xenograft have been successfully used in dental surgeries to promote new bone growth and preserve extraction sockets. These materials help in forming new bone and integrating well with existing bone, which suggests they could be effective in similar treatments like CEBX.12345

Is the use of bone grafts for tooth extractions safe?

Research indicates that demineralized freeze-dried bone allografts (DFDBA) and freeze-dried bone allografts (FDBA) are generally safe for use in humans, as they integrate well with new bone and show no significant inflammatory reactions.13467

How is the treatment CEBX, FDBA different from other treatments for bone grafts after tooth extractions?

The treatment using CEBX and FDBA is unique because it combines collagen-enriched bovine xenograft and freeze-dried bone allografts, which are known for their potential to promote new bone growth and maintain the shape of the jawbone after tooth extraction. This combination may offer enhanced bone healing and stability compared to other treatments.12346

What is the purpose of this trial?

The purpose of this study is to compare two different bone graft materials (freeze-dried bone allograft, FDBA and collagen-enriched bovine xenograft, CEBX) that are routinely used for preserving the remaining bone after extraction of an anterior tooth, and before placing a dental implant. Patients will be randomly assigned to either group (flip of a coin) One group will receive FDBA material and the other group will receive CEBX (cow) material.The study aims to examine the following main questions:* Potential differences in linear radiographic horizontal (HRD) and vertical (VRD) ridge dimensional changes between groups after 16 weeks of healing* Other clinical information of the treated areas and information regarding the esthetics of the dental implant that will subsequently be placed at the edentulous site as well as patient satisfaction with the treatment, will be evaluated.The study will include 7 study visits. Study procedures will take place during the same visits as the standard of care treatments (tooth extraction and bone graft, dental implant placement, crown installation and follow-ups). Clinical information from these standard of care visits will be used for the current research study, such as:* Demographic information* Clinical information from intraoral photographs* Radiographic information from cone beam computed tomography and periapical radiographs.

Research Team

EA

Elli Anna Kotsailidi, DDS, MS

Principal Investigator

Eastman Institute for Oral Health, University of Rochester

Eligibility Criteria

This trial is for individuals needing a front tooth extracted and replaced with an implant. They should be suitable for bone grafting procedures using either human (FDBA) or cow-derived (CEBX) materials. Specific eligibility criteria are not provided, but typically participants must be in good general health and have adequate bone structure to support the dental work.

Inclusion Criteria

My dental scan shows my front tooth's bone is intact or slightly damaged.
Patients able to provide informed consent
I need at least one front tooth pulled out and plan to get a dental implant.

Exclusion Criteria

Uncontrolled diabetes (HbA1c≥7 in the last 3 months)
I need a tooth pulled next to a gap in my front teeth.
Current smokers or tobacco-product users (self-reported)
See 8 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks
1 visit (in-person)

Treatment

Participants undergo tooth extraction and alveolar ridge preservation with either FDBA or CEBX, followed by healing

16 weeks
Multiple visits aligned with standard of care procedures

Implant Placement and Crown Restoration

Implant placement and crown restoration are performed after healing

Approximately 2 weeks
1-2 visits (in-person)

Follow-up

Participants are monitored for safety, effectiveness, and esthetic outcomes after implant placement

12 months
Regular follow-up visits at 2 and 12 months post-implant

Treatment Details

Interventions

  • CEBX
  • FDBA
Trial Overview The study compares two types of bone grafts: FDBA from humans and CEBX from cows, used after removing a front tooth. It aims to see which material better preserves jawbone shape over 16 weeks before placing an implant. Participants will randomly receive one type of graft during standard care visits.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: FDBA armExperimental Treatment1 Intervention
Group II: CEBX armActive Control1 Intervention

CEBX is already approved in European Union, United States, Canada for the following indications:

🇪🇺
Approved in European Union as Bio-Oss Collagen for:
  • Dental implantology
  • Bone augmentation
  • Sinus floor elevation
  • Ridge preservation
🇺🇸
Approved in United States as Bio-Oss Collagen for:
  • Dental implantology
  • Bone augmentation
  • Sinus floor elevation
  • Ridge preservation
🇨🇦
Approved in Canada as Bio-Oss Collagen for:
  • Dental implantology
  • Bone augmentation
  • Sinus floor elevation
  • Ridge preservation

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Rochester

Lead Sponsor

Trials
883
Recruited
555,000+

Implant Dentistry Research & Education Foundation (IDREF)

Collaborator

Trials
1
Recruited
50+

Findings from Research

In a study involving 36 mice, Bio-Oss showed significantly greater bone volume compared to demineralized freeze-dried bone allograft (DFDBA) and control groups at both 1 and 3 months after grafting, indicating its superior efficacy in promoting bone regeneration.
Both Bio-Oss and DFDBA increased the expression of key bone marker genes over time, with Bio-Oss exhibiting particularly strong osteoconductive properties, suggesting it may be more effective for bone healing.
Gene Expression and Microcomputed Tomography Analysis of Grafted Bone Using Deproteinized Bovine Bone and Freeze-Dried Human Bone.Kangwannarongkul, T., Subbalekha, K., Vivatbutsiri, P., et al.[2019]
Demineralized freeze-dried bone allografts (DFDBA) like Osseo+, AlloOss, and Cenobone show osteoinductive activity in vitro, promoting osteogenic differentiation in human osteoblast-like cells (SaOS-2) when tested at a concentration of 16 mg/mL.
While lower concentrations (8 mg/mL) of Osseo+ and Cenobone increased cell proliferation, higher concentrations (16 mg/mL) led to decreased proliferation but enhanced mineralization and osteogenic gene expression, indicating a complex relationship between concentration and cellular response.
In vitro assay for osteoinductive activity of different demineralized freeze-dried bone allograft.Vaziri, S., Vahabi, S., Torshabi, M., et al.[2022]
In a study involving 6 patients and 7 extraction sites, demineralized freeze-dried bone allografts (DFDBA) were found to be well incorporated into new bone up to 13 months after treatment, indicating their potential for promoting bone growth.
Histological analysis showed that DFDBA particles remained identifiable and were surrounded by new bone without significant inflammation or fibrous encapsulation, suggesting a favorable environment for bone regeneration in extraction sockets.
Histologic evaluation of human extraction sockets treated with demineralized freeze-dried bone allograft (DFDBA) and cell occlusive membrane.Brugnami, F., Then, PR., Moroi, H., et al.[2008]

References

Gene Expression and Microcomputed Tomography Analysis of Grafted Bone Using Deproteinized Bovine Bone and Freeze-Dried Human Bone. [2019]
In vitro assay for osteoinductive activity of different demineralized freeze-dried bone allograft. [2022]
Histologic evaluation of human extraction sockets treated with demineralized freeze-dried bone allograft (DFDBA) and cell occlusive membrane. [2008]
Evaluation of healing following tooth extraction with ridge preservation using cortical versus cancellous freeze-dried bone allograft. [2014]
Comparative histomorphometric analysis of extraction sockets healing implanted with bovine xenografts, irradiated cancellous allografts, and solvent-dehydrated allografts in humans. [2009]
Protocol for Maintaining Alveolar Ridge Volume in Molar Immediate Implant Sites. [2020]
Histologic comparison of healing after tooth extraction with ridge preservation using mineralized versus demineralized freeze-dried bone allograft. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security